{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:00:51Z","timestamp":1789743651271,"version":"4.0.1"},"reference-count":36,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6,28]]},"abstract":"<jats:p>Serial plasma aliquots (50 mL) obtained from 10 commercial donors who converted from hepatitis C virus (HCV) RNA negative to positive were transfused into 2 chimpanzees to assess infectivity during early HCV infection. Plasma, obtained 4 days before HCV RNA detectability by licensed assays, transmitted HCV infection to chimpanzee X355. The infectious PCR-negative plasma was subsequently shown to be positive in 2 of 23 replicates using a sensitive transcription-mediated amplification (TMA) assay, and estimated to contain 1.2 HCV RNA copies\/mL (60 copies\/50 mL transfused). Plasma units obtained up to 8 weeks earlier were not infectious in a second susceptible chimp, even when from donors with low-level, intermittent HCV RNA detection. Chimp x355 developed acute viremia with subsequent seroconversion, but cleared both virus and Ab in 17 weeks. When rechallenged 38 months later with 6000 RNA copies\/mL from the same donor, X355 was transiently reinfected and again rapidly lost all HCV markers. We conclude that: (1) transfusions can transmit HCV infection before RNA detection, but the interval of test-negative infectivity is very brief; (2) early \u201cblips\u201d of HCV RNA appear noninfectious and can be ignored when calculating residual transfusion risk; and (3) markers of HCV infection can be lost rapidly after exposure to low-dose inocula.<\/jats:p>","DOI":"10.1182\/blood-2011-12-393637","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T01:02:33Z","timestamp":1334278953000},"page":"6326-6334","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes"],"prefix":"10.1182","volume":"119","author":[{"given":"Michael P.","family":"Busch","sequence":"first","affiliation":[{"name":"Blood Systems Research Institute, San Francisco, CA;"},{"name":"Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna K.","family":"Murthy","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute and Southwest National Primate Research Center, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Kleinman","sequence":"additional","affiliation":[{"name":"Blood Systems Research Institute, San Francisco, CA;"},{"name":"Department of Pathology, University of British Columbia, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale F.","family":"Hirschkorn","sequence":"additional","affiliation":[{"name":"Blood Systems Research Institute, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda L.","family":"Herring","sequence":"additional","affiliation":[{"name":"Blood Systems Research Institute, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Delwart","sequence":"additional","affiliation":[{"name":"Blood Systems Research Institute, San Francisco, CA;"},{"name":"Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[{"name":"Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Chun","family":"Yoon","sequence":"additional","affiliation":[{"name":"Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rehermann","sequence":"additional","affiliation":[{"name":"Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey J.","family":"Alter","sequence":"additional","affiliation":[{"name":"Infectious Disease Section, Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111821414365800_B1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection.","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"issue":"11","key":"2019111821414365800_B2","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1537-2995.2009.02322.x","article-title":"Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.","volume":"49","author":"Kleinman","year":"2009","journal-title":"Transfusion"},{"issue":"12","key":"2019111821414365800_B3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1086\/657318","article-title":"Acute hepatitis C virus infection: a dynamic-and challenging-concept.","volume":"202","author":"Irving","year":"2010","journal-title":"J Infect Dis"},{"issue":"7","key":"2019111821414365800_B4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1537-2995.2009.02266.x","article-title":"Exposed or not exposed\u2013that is the question: evidence for resolving and abortive hepatitis C virus infections in blood donors.","volume":"49","author":"Widell","year":"2009","journal-title":"Transfusion"},{"issue":"2","key":"2019111821414365800_B5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.01229-07","article-title":"Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.","volume":"46","author":"Page-Shafer","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2019111821414365800_B6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.","volume":"200","author":"Page","year":"2009","journal-title":"J Infect Dis"},{"issue":"2","key":"2019111821414365800_B7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2893.2007.00900.x","article-title":"The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.","volume":"15","author":"Mosley","year":"2008","journal-title":"J Viral Hepat"},{"issue":"2","key":"2019111821414365800_B8","first-page":"133","article-title":"Intermittent low-level viremia in very early primary HIV-1 infection.","volume":"39","author":"Fiebig","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"2019111821414365800_B9","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/JVI.02423-08","article-title":"High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection.","volume":"83","author":"Ma","year":"2009","journal-title":"J Virol"},{"issue":"2","key":"2019111821414365800_B10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"issue":"8","key":"2019111821414365800_B11","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1537-2995.2002.00200.x","article-title":"International application of the incidence rate\/window period model.","volume":"42","author":"Glynn","year":"2002","journal-title":"Transfusion"},{"issue":"3","key":"2019111821414365800_B12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/tmrv.1997.0110155","article-title":"The incidence\/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.","volume":"11","author":"Kleinman","year":"1997","journal-title":"Transfus Med Rev"},{"issue":"7","key":"2019111821414365800_B13","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111821414365800_B14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000076643","article-title":"Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission.","volume":"47","author":"Katayama","year":"2004","journal-title":"Intervirology"},{"issue":"3","key":"2019111821414365800_B15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2893.2004.00505.x","article-title":"Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections.","volume":"11","author":"Prince","year":"2004","journal-title":"J Viral Hepat"},{"issue":"2","key":"2019111821414365800_B16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0042-6822(03)00461-6","article-title":"Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.","volume":"314","author":"Shata","year":"2003","journal-title":"Virology"},{"issue":"3","key":"2019111821414365800_B17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/AAC.01032-08","article-title":"Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees.","volume":"53","author":"Carroll","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2019111821414365800_B18","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/AAC.00723-07","article-title":"Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model.","volume":"51","author":"Chen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"2019111821414365800_B19","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.0702162104","article-title":"Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.","volume":"104","author":"Elmowalid","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111821414365800_B20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat Med"},{"issue":"5645","key":"2019111821414365800_B21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help.","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"issue":"7053","key":"2019111821414365800_B22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature04081","article-title":"Prospects for a vaccine against the hepatitis C virus.","volume":"436","author":"Houghton","year":"2005","journal-title":"Nature"},{"issue":"1","key":"2019111821414365800_B23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/JVI.78.1.187-196.2004","article-title":"Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.","volume":"78","author":"Rollier","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"2019111821414365800_B24","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"2019111821414365800_B25","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1537-2995.2005.00649.x","article-title":"Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"issue":"5","key":"2019111821414365800_B26","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/JCM.40.5.1761-1766.2002","article-title":"Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay.","volume":"40","author":"Kolk","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2019111821414365800_B27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"2019111821414365800_B28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.20253","article-title":"Effects of antiviral therapy on the cellular immune response in acute hepatitis C.","volume":"40","author":"Rahman","year":"2004","journal-title":"Hepatology"},{"issue":"8","key":"2019111821414365800_B29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1537-2995.2003.00524.x","article-title":"Very low level viremia in HCV infectious unit missed by NAT.","volume":"43","author":"Busch","year":"2003","journal-title":"Transfusion"},{"issue":"1","key":"2019111821414365800_B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2008.09.001","article-title":"Cost-effectiveness analysis: what it really means for transfusion medicine decision making.","volume":"23","author":"Custer","year":"2009","journal-title":"Transfus Med Rev"},{"issue":"8","key":"2019111821414365800_B31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMoa040085","article-title":"Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.","volume":"351","author":"Stramer","year":"2004","journal-title":"N Engl J Med"},{"issue":"9316","key":"2019111821414365800_B32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C.","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"2019111821414365800_B33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/jhep.2001.21905","article-title":"Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study.","volume":"33","author":"Seeff","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"2019111821414365800_B34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1537-2995.2004.00656.x","article-title":"Complete or partial seroreversion in immunocompetent individuals after self-limited HCV infection: consequences for transfusion.","volume":"44","author":"Lefrere","year":"2004","journal-title":"Transfusion"},{"issue":"3","key":"2019111821414365800_B35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1423-0410.1999.7630138.x","article-title":"Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.","volume":"76","author":"Lawlor","year":"1999","journal-title":"Vox Sang"},{"issue":"3","key":"2019111821414365800_B36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1423-0410.1999.7630175.x","article-title":"A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland.","volume":"76","author":"Smith","year":"1999","journal-title":"Vox Sang"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/26\/6326\/1497917\/zh802612006326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/26\/6326\/1497917\/zh802612006326.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T21:42:10Z","timestamp":1574113330000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/26\/6326\/105608\/Infectivity-in-chimpanzees-Pan-troglodytes-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,28]]},"references-count":36,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2012,6,28]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-12-393637","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,28]]}}}